ER status is extremely important since ER+ cancers grow under the influence of estrogen, and may therefore respond well to hormone suppression treatments, while the proliferation of ER− cancers is not driven by estrogen and does not respond to estrogen modulation. This evidence concerns the gene ESR1 and cancer.